 | • レポートコード：B-GIR09D4128 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、代謝障害治療薬の世界市場について調べ、まとめました。種類別セグメントは、リソソーム蓄積症、糖尿病、肥満、遺伝性代謝障害、高コレステロール血症等、用途別セグメントは、経口、非経口、その他等に区分しました。代謝障害治療薬の世界市場概観、企業動向、企業別代謝障害治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・代謝障害治療薬の市場概観 ・代謝障害治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・代謝障害治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・代謝障害治療薬の世界市場規模 ・代謝障害治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・代謝障害治療薬のアメリカ市場規模推移 ・代謝障害治療薬のカナダ市場規模推移 ・代謝障害治療薬のメキシコ市場規模推移 ・代謝障害治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・代謝障害治療薬のドイツ市場規模推移 ・代謝障害治療薬のイギリス市場規模推移 ・代謝障害治療薬のロシア市場規模推移 ・代謝障害治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・代謝障害治療薬の日本市場規模推移 ・代謝障害治療薬の中国市場規模推移 ・代謝障害治療薬の韓国市場規模推移 ・代謝障害治療薬のインド市場規模推移 ・代謝障害治療薬の東南アジア市場規模推移 ・代謝障害治療薬の南米市場分析（ブラジル、アルゼンチン等） ・代謝障害治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・代謝障害治療薬の種類別分析/販売量、売上、市場シェア（リソソーム蓄積症、糖尿病、肥満、遺伝性代謝障害、高コレステロール血症） ・代謝障害治療薬の用途別分析/市場規模（経口、非経口、その他） ・代謝障害治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・代謝障害治療薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
Increasing demand for one-time therapies for metabolic disorders and rising prevalence of lifestyle diseases are the key factors that are expected to boost the growth of this market.
The global Metabolic Disorder Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Metabolic Disorder Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Metabolic Disorder Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Metabolic Disorder Therapeutics market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novo Nordisk A/S
Sanofi S.A.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck KgaA
Amgen, Inc.
AstraZeneca PLC
Actelion Pharmaceuticals Ltd.
Shire PLC
AbbVie, Inc.
Biocon Ltd.
BioMarin Pharmaceutical, Inc.
Bristol-Myers Squibb Company
Cipla, Inc.
CymaBay Therapeutics, Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Lysosomal Storage Diseases
Diabetes
Obesity
Inherited Metabolic Disorders
Hypercholesterolemia
Market Segment by Applications, can be divided into
Oral
Parenteral
Others
Table of Contents
1 Metabolic Disorder Therapeutics Market Overview
1.1 Product Overview and Scope of Metabolic Disorder Therapeutics
1.2 Classification of Metabolic Disorder Therapeutics by Types
1.2.1 Global Metabolic Disorder Therapeutics Revenue Comparison by Types (2019-2024)
1.2.2 Global Metabolic Disorder Therapeutics Revenue Market Share by Types in 2018
1.2.3 Lysosomal Storage Diseases
1.2.4 Diabetes
1.2.5 Obesity
1.2.6 Inherited Metabolic Disorders
1.2.7 Hypercholesterolemia
1.3 Global Metabolic Disorder Therapeutics Market by Application
1.3.1 Global Metabolic Disorder Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Others
1.4 Global Metabolic Disorder Therapeutics Market by Regions
1.4.1 Global Metabolic Disorder Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Metabolic Disorder Therapeutics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Metabolic Disorder Therapeutics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metabolic Disorder Therapeutics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Metabolic Disorder Therapeutics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metabolic Disorder Therapeutics Status and Prospect (2014-2024)
1.5 Global Market Size of Metabolic Disorder Therapeutics (2014-2024)
2 Manufacturers Profiles
2.1 Novo Nordisk A/S
2.1.1 Business Overview
2.1.2 Metabolic Disorder Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novo Nordisk A/S Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi S.A.
2.2.1 Business Overview
2.2.2 Metabolic Disorder Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi S.A. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Boehringer Ingelheim GmbH
2.3.1 Business Overview
2.3.2 Metabolic Disorder Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.4 Eli Lilly and Company
2.4.1 Business Overview
2.4.2 Metabolic Disorder Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly and Company Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck KgaA
2.5.1 Business Overview
2.5.2 Metabolic Disorder Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck KgaA Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Amgen, Inc.
2.6.1 Business Overview
2.6.2 Metabolic Disorder Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Amgen, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.7 AstraZeneca PLC
2.7.1 Business Overview
2.7.2 Metabolic Disorder Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AstraZeneca PLC Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Actelion Pharmaceuticals Ltd.
2.8.1 Business Overview
2.8.2 Metabolic Disorder Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Shire PLC
2.9.1 Business Overview
2.9.2 Metabolic Disorder Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Shire PLC Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.10 AbbVie, Inc.
2.10.1 Business Overview
2.10.2 Metabolic Disorder Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AbbVie, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.11 Biocon Ltd.
2.11.1 Business Overview
2.11.2 Metabolic Disorder Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biocon Ltd. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.12 BioMarin Pharmaceutical, Inc.
2.12.1 Business Overview
2.12.2 Metabolic Disorder Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 BioMarin Pharmaceutical, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.13 Bristol-Myers Squibb Company
2.13.1 Business Overview
2.13.2 Metabolic Disorder Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Bristol-Myers Squibb Company Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.14 Cipla, Inc.
2.14.1 Business Overview
2.14.2 Metabolic Disorder Therapeutics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Cipla, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.15 CymaBay Therapeutics, Inc.
2.15.1 Business Overview
2.15.2 Metabolic Disorder Therapeutics Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 CymaBay Therapeutics, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Metabolic Disorder Therapeutics Market Competition, by Players
3.1 Global Metabolic Disorder Therapeutics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Metabolic Disorder Therapeutics Players Market Share
3.2.2 Top 10 Metabolic Disorder Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Metabolic Disorder Therapeutics Market Size by Regions
4.1 Global Metabolic Disorder Therapeutics Revenue and Market Share by Regions
4.2 North America Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
4.3 Europe Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
4.5 South America Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Metabolic Disorder Therapeutics Revenue by Countries
5.1 North America Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
5.2 USA Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
5.3 Canada Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
5.4 Mexico Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Metabolic Disorder Therapeutics Revenue by Countries
6.1 Europe Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
6.2 Germany Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
6.3 UK Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
6.4 France Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
6.5 Russia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
6.6 Italy Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Metabolic Disorder Therapeutics Revenue by Countries
7.1 Asia-Pacific Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
7.2 China Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
7.3 Japan Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
7.4 Korea Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
7.5 India Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Metabolic Disorder Therapeutics Revenue by Countries
8.1 South America Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
8.2 Brazil Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
8.3 Argentina Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
8.4 Colombia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Metabolic Disorder Therapeutics by Countries
9.1 Middle East and Africa Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
9.3 UAE Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
9.4 Egypt Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
9.6 South Africa Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Metabolic Disorder Therapeutics Market Segment by Type
10.1 Global Metabolic Disorder Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Global Metabolic Disorder Therapeutics Market Forecast by Type (2019-2024)
10.3 Lysosomal Storage Diseases Revenue Growth Rate (2014-2024)
10.4 Diabetes Revenue Growth Rate (2014-2024)
10.5 Obesity Revenue Growth Rate (2014-2024)
10.6 Inherited Metabolic Disorders Revenue Growth Rate (2014-2024)
10.7 Hypercholesterolemia Revenue Growth Rate (2014-2024)
11 Global Metabolic Disorder Therapeutics Market Segment by Application
11.1 Global Metabolic Disorder Therapeutics Revenue Market Share by Application (2014-2019)
11.2 Metabolic Disorder Therapeutics Market Forecast by Application (2019-2024)
11.3 Oral Revenue Growth (2014-2019)
11.4 Parenteral Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Metabolic Disorder Therapeutics Market Size Forecast (2019-2024)
12.1 Global Metabolic Disorder Therapeutics Market Size Forecast (2019-2024)
12.2 Global Metabolic Disorder Therapeutics Market Forecast by Regions (2019-2024)
12.3 North America Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
12.4 Europe Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
12.6 South America Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Metabolic Disorder Therapeutics Picture
Table Product Specifications of Metabolic Disorder Therapeutics
Table Global Metabolic Disorder Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Metabolic Disorder Therapeutics Revenue Market Share by Types in 2018
Figure Lysosomal Storage Diseases Picture
Figure Diabetes Picture
Figure Obesity Picture
Figure Inherited Metabolic Disorders Picture
Figure Hypercholesterolemia Picture
Table Global Metabolic Disorder Therapeutics Revenue (Million USD) by Application (2014-2024)
Figure Metabolic Disorder Therapeutics Revenue Market Share by Applications in 2018
Figure Oral Picture
Figure Parenteral Picture
Figure Others Picture
Table Global Market Metabolic Disorder Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Metabolic Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Metabolic Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Metabolic Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Metabolic Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Metabolic Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Metabolic Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Table Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk A/S Metabolic Disorder Therapeutics Type and Applications
Table Novo Nordisk A/S Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table Sanofi S.A. Metabolic Disorder Therapeutics Type and Applications
Table Sanofi S.A. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Type and Applications
Table Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Metabolic Disorder Therapeutics Type and Applications
Table Eli Lilly and Company Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Merck KgaA Basic Information, Manufacturing Base and Competitors
Table Merck KgaA Metabolic Disorder Therapeutics Type and Applications
Table Merck KgaA Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table Amgen, Inc. Metabolic Disorder Therapeutics Type and Applications
Table Amgen, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca PLC Basic Information, Manufacturing Base and Competitors
Table AstraZeneca PLC Metabolic Disorder Therapeutics Type and Applications
Table AstraZeneca PLC Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Actelion Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Type and Applications
Table Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Shire PLC Basic Information, Manufacturing Base and Competitors
Table Shire PLC Metabolic Disorder Therapeutics Type and Applications
Table Shire PLC Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
Table AbbVie, Inc. Metabolic Disorder Therapeutics Type and Applications
Table AbbVie, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Ltd. Basic Information, Manufacturing Base and Competitors
Table Biocon Ltd. Metabolic Disorder Therapeutics Type and Applications
Table Biocon Ltd. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table BioMarin Pharmaceutical, Inc. Basic Information, Manufacturing Base and Competitors
Table BioMarin Pharmaceutical, Inc. Metabolic Disorder Therapeutics Type and Applications
Table BioMarin Pharmaceutical, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Metabolic Disorder Therapeutics Type and Applications
Table Bristol-Myers Squibb Company Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla, Inc. Basic Information, Manufacturing Base and Competitors
Table Cipla, Inc. Metabolic Disorder Therapeutics Type and Applications
Table Cipla, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table CymaBay Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table CymaBay Therapeutics, Inc. Metabolic Disorder Therapeutics Type and Applications
Table CymaBay Therapeutics, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Metabolic Disorder Therapeutics Revenue (Million USD) by Players (2014-2019)
Table Global Metabolic Disorder Therapeutics Revenue Share by Players (2014-2019)
Figure Global Metabolic Disorder Therapeutics Revenue Share by Players in 2017
Figure Global Metabolic Disorder Therapeutics Revenue Share by Players in 2018
Figure Global Top 5 Players Metabolic Disorder Therapeutics Revenue Market Share in 2018
Figure Global Top 10 Players Metabolic Disorder Therapeutics Revenue Market Share in 2018
Figure Global Metabolic Disorder Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Metabolic Disorder Therapeutics Revenue (Million USD) by Regions (2014-2019)
Table Global Metabolic Disorder Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Metabolic Disorder Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Metabolic Disorder Therapeutics Revenue Market Share by Regions in 2018
Figure North America Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Europe Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure South America Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
Table North America Metabolic Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Metabolic Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Metabolic Disorder Therapeutics Revenue Market Share by Countries in 2018
Figure USA Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Canada Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Mexico Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Metabolic Disorder Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Metabolic Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe Metabolic Disorder Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure UK Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure France Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Russia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Italy Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Metabolic Disorder Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Metabolic Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Metabolic Disorder Therapeutics Revenue Market Share by Countries in 2018
Figure China Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Japan Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Korea Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure India Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Metabolic Disorder Therapeutics Revenue by Countries (2014-2019)
Table South America Metabolic Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Metabolic Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Metabolic Disorder Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Argentina Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Colombia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Metabolic Disorder Therapeutics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Metabolic Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Metabolic Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Metabolic Disorder Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure UAE Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Egypt Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Nigeria Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure South Africa Metabolic Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Metabolic Disorder Therapeutics Revenue (Million USD) by Type (2014-2019)
Table Global Metabolic Disorder Therapeutics Revenue Share by Type (2014-2019)
Figure Global Metabolic Disorder Therapeutics Revenue Share by Type (2014-2019)
Figure Global Metabolic Disorder Therapeutics Revenue Share by Type in 2019
Table Global Metabolic Disorder Therapeutics Revenue Forecast by Type (2019-2024)
Figure Global Metabolic Disorder Therapeutics Market Share Forecast by Type (2019-2024)
Figure Global Lysosomal Storage Diseases Revenue Growth Rate (2014-2019)
Figure Global Diabetes Revenue Growth Rate (2014-2019)
Figure Global Obesity Revenue Growth Rate (2014-2019)
Figure Global Inherited Metabolic Disorders Revenue Growth Rate (2014-2019)
Figure Global Hypercholesterolemia Revenue Growth Rate (2014-2019)
Table Global Metabolic Disorder Therapeutics Revenue by Application (2014-2019)
Table Global Metabolic Disorder Therapeutics Revenue Share by Application (2014-2019)
Figure Global Metabolic Disorder Therapeutics Revenue Share by Application (2014-2019)
Figure Global Metabolic Disorder Therapeutics Revenue Share by Application in 2019
Table Global Metabolic Disorder Therapeutics Revenue Forecast by Application (2019-2024)
Figure Global Metabolic Disorder Therapeutics Market Share Forecast by Application (2019-2024)
Figure Global Oral Revenue Growth Rate (2014-2019)
Figure Global Parenteral Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Metabolic Disorder Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Metabolic Disorder Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Metabolic Disorder Therapeutics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
Figure Europe Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
Figure South America Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Metabolic Disorder Therapeutics Revenue Market Forecast (2019-2024)
世界の筋骨格障害幹細胞療法市場予測（～2024年） Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy. Scope of the Report: The global Musculoskeletal Disorder Stem Cell Therapy market is valued at xx million USD in 2018 and is expected to reach…- 世界の季節性情動障害光療法市場予測（～2024年） Light therapy is a way to treat seasonal affective disorder (SAD) and certain other conditions by exposure to artificial light. Scope of the Report: The global Seasonal Affective Disorder Light Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2…
- 世界の季節性情動障害薬市場予測（～2024年） Seasonal affective disorder or SAD is a recurrent major depressive disorder with a seasonal pattern usually beginning in fall and continuing into winter months. Scope of the Report: The worldwide market for Seasonal Affective Disorder Drugs is expected to grow at a CAGR of roughly xx% over the next …
- 世界の季節性情動障害装置市場予測（～2024年） Seasonal affective disorder or SAD is a recurrent major depressive disorder with a seasonal pattern usually beginning in fall and continuing into winter months. Scope of the Report: The worldwide market for Seasonal Affective Disorder Devices is expected to grow at a CAGR of roughly xx% over the nex…
- 世界の頭蓋内出血治療市場予測（～2024年） Intracranial hemorrhage is a type of bleeding that occurs inside the skull. Intracranial Hemorrhage Medication is principally focused on adjunctive measures to minimize injury and to stabilize individuals in the perioperative phase.There are several kinds of intracranial hemorrhage medications, such…